Jason A Collett Selected Research

Butylated Hydroxytoluene (BHT)

10/2013

Renal angiotensin II type 1 receptor expression and associated hypertension in rats with minimal SHR nuclear genome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason A Collett Research Topics

Disease

6	Ischemia 04/2024 - 10/2015
4	Acute Kidney Injury (Acute Renal Failure) 04/2024 - 10/2015
4	Inflammation (Inflammations) 04/2024 - 10/2015
4	Fibrosis (Cirrhosis) 10/2023 - 10/2015
1	Critical Illness (Critically Ill) 01/2022
1	Hypoxia (Hypoxemia) 01/2018
1	Microvascular Rarefaction 01/2017
1	Chronic Renal Insufficiency 10/2015
1	Hypertension (High Blood Pressure) 10/2013

Drug/Important Bio-Agent (IBA)

3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2018
2	CreatinineIBA 04/2024 - 01/2024
2	salicylhydroxamic acid (SHAM)IBA 10/2023 - 10/2015
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018 - 01/2017
1	Angiopoietin-2IBA 04/2024
1	Member 3 Group F Nuclear Receptor Subfamily 1IBA 11/2020
1	NADP (NADPH)IBA 01/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018
1	CytokinesIBA 01/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017
1	Losartan (Cozaar)FDA LinkGeneric 01/2017
1	SaltsIBA 10/2015
1	Angiotensin IIIBA 10/2013
1	Type 1 Angiotensin ReceptorIBA 10/2013
1	Butylated Hydroxytoluene (BHT)IBA 10/2013

Therapy/Procedure

2	Nephrectomy 10/2023 - 10/2015
1	Subcutaneous Injections 04/2024
1	Therapeutics 01/2017